Considering the vital role of the TLR4–NF-κB signaling pathway in mediating the synergistic stimulation of spike protein and IL-2 in inducing inflammatory cytokines, this pathway presents a promising target for preventing or reducing CRS in patients with COVID-19. The gene discussed is TLR4; the disease is COVID-19.